[go: up one dir, main page]

BR9201771A - COMPOUNDS, AMINO ACID DERIVATIVE, PROCESS FOR ITS MANUFACTURE, MEDICINE, APPLICATION OF THE MENTIONED DERIVATIVE AND PROCESS TO TREAT OR PREVENT VIA INFECTIONS - Google Patents

COMPOUNDS, AMINO ACID DERIVATIVE, PROCESS FOR ITS MANUFACTURE, MEDICINE, APPLICATION OF THE MENTIONED DERIVATIVE AND PROCESS TO TREAT OR PREVENT VIA INFECTIONS

Info

Publication number
BR9201771A
BR9201771A BR929201771A BR9201771A BR9201771A BR 9201771 A BR9201771 A BR 9201771A BR 929201771 A BR929201771 A BR 929201771A BR 9201771 A BR9201771 A BR 9201771A BR 9201771 A BR9201771 A BR 9201771A
Authority
BR
Brazil
Prior art keywords
derivative
infections
treat
medicine
compounds
Prior art date
Application number
BR929201771A
Other languages
Portuguese (pt)
Inventor
Joseph Armstrong Martin
Gareth John Thomas
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority to BR929201771A priority Critical patent/BR9201771A/en
Publication of BR9201771A publication Critical patent/BR9201771A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/57Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/62Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/24Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
    • C07C255/29Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton containing cyano groups and acylated amino groups bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR929201771A 1991-05-10 1992-05-11 COMPOUNDS, AMINO ACID DERIVATIVE, PROCESS FOR ITS MANUFACTURE, MEDICINE, APPLICATION OF THE MENTIONED DERIVATIVE AND PROCESS TO TREAT OR PREVENT VIA INFECTIONS BR9201771A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR929201771A BR9201771A (en) 1991-05-10 1992-05-11 COMPOUNDS, AMINO ACID DERIVATIVE, PROCESS FOR ITS MANUFACTURE, MEDICINE, APPLICATION OF THE MENTIONED DERIVATIVE AND PROCESS TO TREAT OR PREVENT VIA INFECTIONS

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919110170A GB9110170D0 (en) 1991-05-10 1991-05-10 Amino acid derivatives
BR929201771A BR9201771A (en) 1991-05-10 1992-05-11 COMPOUNDS, AMINO ACID DERIVATIVE, PROCESS FOR ITS MANUFACTURE, MEDICINE, APPLICATION OF THE MENTIONED DERIVATIVE AND PROCESS TO TREAT OR PREVENT VIA INFECTIONS

Publications (1)

Publication Number Publication Date
BR9201771A true BR9201771A (en) 1992-12-29

Family

ID=10694788

Family Applications (1)

Application Number Title Priority Date Filing Date
BR929201771A BR9201771A (en) 1991-05-10 1992-05-11 COMPOUNDS, AMINO ACID DERIVATIVE, PROCESS FOR ITS MANUFACTURE, MEDICINE, APPLICATION OF THE MENTIONED DERIVATIVE AND PROCESS TO TREAT OR PREVENT VIA INFECTIONS

Country Status (8)

Country Link
KR (1) KR100220987B1 (en)
BR (1) BR9201771A (en)
GB (2) GB9110170D0 (en)
RU (1) RU2109731C1 (en)
TW (1) TW264462B (en)
UY (1) UY23413A1 (en)
YU (1) YU49092A (en)
ZA (1) ZA923184B (en)

Also Published As

Publication number Publication date
ZA923184B (en) 1993-10-04
UY23413A1 (en) 1992-11-05
GB9203014D0 (en) 1992-03-25
TW264462B (en) 1995-12-01
RU2109731C1 (en) 1998-04-27
GB9110170D0 (en) 1991-07-03
YU49092A (en) 1995-03-27
KR100220987B1 (en) 1999-10-01
KR920021495A (en) 1992-12-18

Similar Documents

Publication Publication Date Title
BR9401828A (en) Optically active derivatives of 2-imidazolin-5-ones or 2-imidazolin-5-thiones, process for their preparation, optically active intermediate compounds, fungicidal compositions and crop treatment process
PT98944A (en) PROCESS FOR THE PREPARATION OF ALTERED ANTIBODIES AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF INFECTIONS
BR9408148A (en) Process for the treatment of compound arrhythmia and pharmaceutical formulation
BR9407720A (en) Compound pharmaceutical composition and process for the prevention or treatment of immunoregulatory disorders or diseases that comprise the administration of the compound
IT9048260A0 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF RESPIRATORY DISORDERS AND METHOD FOR ITS APPLICATION.
BR9612204A (en) Compound use of the compound Pharmaceutical composition and process for preparing the compound and for treating pain
BG101118A (en) Therapeutical compounds
BR9503638A (en) Compound process for its production and pharmaceutical formulation
BR9004852A (en) COMPOUND, PROCESS FOR ITS PREPARATION, ITS APPLICATION AND PHARMACEUTICAL COMPOSITION
BR9506473A (en) Compound process for the preparation of compounds use of a compound pharmaceutical composition and process for the treatment of anti-fungal infections
BR9101121A (en) COMPOUND, PROCESS FOR ITS PREPARATION, ITS APPLICATIONS, AND PHARMACEUTICAL PREPARATION
BR9502471A (en) Guanidine compound Process for preparing a guanidine compound Pharmaceutical composition Use of a guanidine compound Method for the prophylactic or therapeutic treatment of diseases and process for preparing a pharmaceutical composition
IT9048261A0 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF RESPIRATORY DISORDERS AND METHOD FOR ITS APPLICATION.
BR9204699A (en) COMPOUNDS CONTAINING IMIDAZOLINONE OR IMIDAZOLINTIONA GROUP, PROCESSES OF PREPARATIONS OF THESE COMPOUNDS, FUNGICIDED COMPOSITES AND CULTURE TREATMENT PROCESS
BR8806640A (en) GRANULATES, PHYTOSANITARY TREATMENT PROCESS AND PROCESS FOR PREPARATION OF GRANULATES
PT96379A (en) PROCESS FOR THE PREPARATION OF CYCLOPROPYL-N-HYDROXY-UREES, SUBSTITUTED NON-ACID-N-HYDROXYAMINS AND PHARMACEUTICAL COMPOUNDS
BR9607346A (en) Compound use of a compound, pharmaceutical composition and process for the treatment of a mammal and for and preparation of compounds
BR9302389A (en) COMPOUND, PHARMACEUTICAL FORMULATION AND PROCESS TO PREPARE THE COMPOUND
BR9203508A (en) COMPOUND, PROCESS FOR ITS PREPARATION, MEDICINE, USE IN A COMPOUND AND METHOD OF TREATING OR AVOIDING INFLAMMATORY DISEASES
BR9204643A (en) MEDICINAL PRODUCT, PROCESS FOR SYNTHESIS OF CYSTEAMINE MELAMINYL THYLARSENIATE DYCHLORHYDRATE OR MELARSOMINE DICHYLHYDROCHLOR AND PREPARATIONS OF MELARSOMINE DYCHLORHYDRATE, MELAMINE HYDROHYDRATED HYDROHYDRATED HYDROHYDRATED MIX
BR9101822A (en) COMPOUNDS, PROCESS FOR ITS PRODUCTION, PHARMACEUTICAL PRODUCT, PROCESS FOR ITS PRODUCTION, APPLICATION OF SUCH COMPOUNDS, AND PROCESSES FOR TREATING MALARIA AND VIROTIC DISEASES
BR9006502A (en) COMPOUND AND PROCESS FOR ITS PRODUCTION, PHARMACEUTICAL COMPOSITION AND METHOD FOR THE TREATMENT OF A HOST ANIMAL
BR9300034A (en) COMPOUND, PROCESS FOR ITS PRODUCTION AND HEALING COMPOSITION
BR9102730A (en) AMINO ACID DERIVATIVES, PROCESS FOR THE PREPARATION OF A COMPOUND, MEDICINE, INVENTION AND PROCESS FOR THE TREATMENT OR PREVENTION OF HIGH PRESSURE
BR8606201A (en) NEMATOCID AND INSECTICID COMPOSITES, PROCESS FOR THE TREATMENT OF PLANTS, COMPOUNDS AND PROCESS FOR ITS PREPARATION

Legal Events

Date Code Title Description
EE Request for examination
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
CKFC Appeal: appeal against refusal
B15K Others concerning applications: alteration of classification

Ipc: C07C 271/20 (2006.01), A61K 31/13 (2006.0